Recent advances in early detection of Breast Cancer in women aged 30 to 50.
DOI:
https://doi.org/10.70577/asce.v5i2.782Keywords:
Cell-free fetal DNA; Prenatal screening; Aneuploidies; Ultrasound markers; First trimester, Breast cancer; Screening; Contrast mammography; Magnetic resonance imagingAbstract
Breast cancer is one of the leading causes of mortality and morbidity among women worldwide, underscoring the importance of early detection through various diagnostic methods to improve prognosis and survival. In recent years, screening strategies and diagnostic tools have advanced significantly, leading to improvements in quality of life. The objective of this study is to analyze recent advances in the early detection of breast cancer in women aged 30 to 50 years through a state-of-the-art review that evaluates their clinical and diagnostic impact. The following databases were used for the literature search: PubMed and Scopus, following the PRISMA methodological guidelines. The findings indicate a trend toward earlier initiation of mammographic screening and the adoption of more advanced imaging techniques, such as digital breast tomosynthesis, contrast-enhanced mammography, automated ultrasound, and magnetic resonance imaging, which have improved diagnostic accuracy, particularly in women with dense breasts. Furthermore, the incorporation of artificial intelligence and molecular biomarkers has fostered a screening approach that is better tailored to individual needs.
Downloads
References
1. Cáncer de mama: riesgos, síntomas y tratamiento oportuno [Internet]. Ministerio de Salud Pública. 2022 [cited 2026 Jan 22]. Available from: https://www.salud.gob.ec/cancer-de-mama-riesgos-sintomas-y-tratamiento-oportuno/
2. Cáncer de mama en las Américas [Internet]. Organización Panamericana de la Salud & Organización Mundial de la Salud . 2018 [cited 2026 Jan 22]. Available from: https://www.paho.org/sites/default/files/Cancer-mama-Americas-factsheet-ES%20%281%29.pdf
3. Bastidas JF, Martínez de Bourio-Allona M, Roteta Unceta Barrenechea A, Rodríguez-Fraile M, Sancho L. PET/CT in breast cancer. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) [Internet]. 2025 Nov [cited 2026 Jan 22];44(6):500139. Available from: https://www.sciencedirect.com/science/article/abs/pii/S2253808925001260?via%3Dihub
4. Todas y cada una juntas en la prevención del cáncer de mama [Internet]. Organización Panamericana de la Salud & Organización Mundial de la Salud . 2025 [cited 2026 Jan 22]. Available from: https://www.paho.org/es/noticias/2-10-2025-todas-cada-juntas-prevencion-cancer-mama
5. Shi J, Li J, Gao Y, Chen W, Zhao L, Li N, et al. The screening value of mammography for breast cancer: an overview of 28 systematic reviews with evidence mapping. J Cancer Res Clin Oncol [Internet]. 2025 Mar 6 [cited 2026 Jan 22];151(3):102. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11885354/
6. Duggan SN, Azharuddin M, Hernández R, Robertson C, Cooper D, McCall E, et al. Supplemental imaging modalities for breast cancer screening in women with dense breasts: A systematic review with economic considerations. The Breast [Internet]. 2026 Feb [cited 2026 Jan 22];85:104668. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12720037/
7. Arenas Rivera EN, Maiques JM, Alcantara R, Román M, Burón A, Sala M, et al. AI WAVEMAR: creación de un modelo de inteligencia artificial para detectar hallazgos sospechosos en la mamografía de cribado. Radiologia [Internet]. 2025 Aug [cited 2026 Jan 22];501741. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0033833825001250
8. El-Toukhy SE, Nabih HK, Kamel MM, Elmasry H, El-Daly SM. Circulating microRNAs and serum proteins in breast cancer patients: Diagnostic relevance and grade-specific expression patterns. World J Exp Med [Internet]. 2025 Sep 20 [cited 2026 Jan 20];15(3). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12781697/pdf/wjem-15-3-108034.pdf
9. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ [Internet]. 2021 Mar 29 [cited 2025 Oct 11];n71. Available from: https://www.bmj.com/content/372/bmj.n71
10. Nicholson WK, Silverstein M, Wong JB, Barry MJ, Chelmow D, Coker TR, et al. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. Vol. 331, JAMA. American Medical Association; 2024. p. 1918–30.
11. Duffy S, Vulkan D, Cuckle H, Parmar D, Sheikh S, Smith R, et al. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT. Health Technol Assess (Rockv) [Internet]. 2020 Oct [cited 2026 Jan 22];24(55):1–24. Available from: https://pubmed.ncbi.nlm.nih.gov/33141657/
12. Monticciolo DL, Hendrick RE, Helvie MA. Outcomes of Breast Cancer Screening Strategies Based on Cancer Intervention and Surveillance Modeling Network Estimates. Radiology [Internet]. 2024 Feb 1 [cited 2026 Jan 22];310(2). Available from: https://pubs.rsna.org/doi/10.1148/radiol.232658
13. Lee CS, Ashih H, Sengupta D, Sickles EA, Zuley M, Pisano E. Risk-Based Screening Mammography for Women Aged <40: Outcomes From the National Mammography Database. Journal of the American College of Radiology [Internet]. 2020 Mar [cited 2026 Jan 22];17(3):368–76. Available from: https://pubmed.ncbi.nlm.nih.gov/31541655/
14. Raichand S, Blaya-Novakova V, Berber S, Livingstone A, Noguchi N, Houssami N. Digital breast tomosynthesis for breast cancer diagnosis in women with dense breasts and additional breast cancer risk factors: A systematic review. The Breast [Internet]. 2024 Oct [cited 2026 Jan 22];77:103767. Available from: https://pubmed.ncbi.nlm.nih.gov/38996609/
15. Liu X, Yang T, Yao J. Impact of digital breast tomosynthesis on screening performance and interval cancer rates compared to digital mammography: A meta-analysis. PLoS One [Internet]. 2025 Jan 31 [cited 2026 Jan 22];20(1):e0315466. Available from: https://pubmed.ncbi.nlm.nih.gov/39888906/
16. Coffey K, Jochelson MS. Contrast-enhanced mammography in breast cancer screening. Eur J Radiol [Internet]. 2022 Nov [cited 2026 Jan 22];156:110513. Available from: https://pubmed.ncbi.nlm.nih.gov/36108478/
17. Bartolović N, Car Peterko A, Avirović M, Šegota Ritoša D, Grgurević Dujmić E, Valković Zujić P. Validation of Contrast-Enhanced Mammography as Breast Imaging Modality Compared to Standard Mammography and Digital Breast Tomosynthesis. Diagnostics [Internet]. 2024 Jul 21 [cited 2026 Jan 22];14(14):1575. Available from: https://www.mdpi.com/2075-4418/14/14/1575
18. Weinstein SP, Slanetz PJ, Lewin AA, Battaglia T, Chagpar AB, Dayaratna S, et al. ACR Appropriateness Criteria® Supplemental Breast Cancer Screening Based on Breast Density. Journal of the American College of Radiology [Internet]. 2021 Nov [cited 2026 Jan 22];18(11):S456–73. Available from: https://pubmed.ncbi.nlm.nih.gov/34794600/
19. Spear GG, Mendelson EB. Automated breast ultrasound: Supplemental screening for average-risk women with dense breasts. Clin Imaging [Internet]. 2021 Aug [cited 2026 Jan 22];76:15–25. Available from: https://pubmed.ncbi.nlm.nih.gov/33548888/
20. Branco PESC, Franco AHS, Oliveira AP de, Carneiro IMC, Carvalho LMC de, Souza JIN de, et al. Artificial intelligence in mammography: a systematic review of the external validation. Revista Brasileira de Ginecologia e Obstetrícia [Internet]. 2024 Sep 4 [cited 2026 Jan 22];46. Available from: https://pubmed.ncbi.nlm.nih.gov/39380589/
21. Huang X, Lott PC, Hu D, Zavala VA, Jamal ZN, Vidaurre T, et al. Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage. Cancer Epidemiology, Biomarkers & Prevention [Internet]. 2025 Feb 6 [cited 2026 Jan 22];34(2):234–45. Available from: https://pubmed.ncbi.nlm.nih.gov/39625644/
22. Berg WA, Vargo A, Lu AH, Berg JM, Bandos AI, Hartman JY, et al. Screening for Breast Cancer with Contrast-enhanced Mammography as an Alternative to MRI: SCEMAM Trial Results. Radiology [Internet]. 2025 Jun 1 [cited 2026 Jan 20];315(3). Available from: https://pubmed.ncbi.nlm.nih.gov/40525975/
23. Gilbert FJ, Payne NR, Allajbeu I, Yit L, Vinnicombe S, Lyburn I, et al. Comparison of supplemental breast cancer imaging techniques—interim results from the BRAID randomised controlled trial. The Lancet [Internet]. 2025 May [cited 2026 Jan 20];405(10493):1935–44. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2825%2900582-3/fulltext
24. Eisemann N, Bunk S, Mukama T, Baltus H, Elsner SA, Gomille T, et al. Nationwide real-world implementation of AI for cancer detection in population-based mammography screening. Nat Med [Internet]. 2025 Mar 7 [cited 2026 Jan 20];31(3):917–24. Available from: https://www.nature.com/articles/s41591-024-03408-6
25. Shen J, Liu Y, Liu A, Gu X, Zhou J, Jiang P, et al. Artificial intelligence-assisted ultrasound screening for breast cancer in China: a prospective, clustered, controlled, population-based study. Breast Cancer Research [Internet]. 2025 Oct 7 [cited 2026 Jan 20];27(1):173. Available from: https://pubmed.ncbi.nlm.nih.gov/41057952/
26. Liu J, Li Y, Tang W, Qian T, Dai L, Jia Z, et al. Cell-free DNA Fragmentomics Assay to Discriminate the Malignancy of Breast Nodules and Evaluate Treatment Response. Genomics Proteomics Bioinformatics [Internet]. 2025 May 30 [cited 2026 Jan 20];23(2). Available from: https://academic.oup.com/gpb/article/23/2/qzaf028/8106494
27. Covington MF. Maximizing Breast Cancer Detection Through Screening: A Comparative Analysis of Imaging-Based Approaches. Clin Breast Cancer [Internet]. 2025 Feb [cited 2026 Jan 20];25(2):117-121.e1. Available from: https://pubmed.ncbi.nlm.nih.gov/39428289/
28. Covington MF, Salmon S, Weaver BD, Fajardo LL. State-of-the-art for contrast-enhanced mammography. British Journal of Radiology. 2024 Mar 28;97(1156):695–704.
29. Tao T, Zhang T, Xu L, Beets-Tan RGH, Shen Y, Karssemeijer N, et al. Multi-modal artificial intelligence for the combination of automated 3D breast ultrasound and mammograms in a population of women with predominantly dense breasts. Insights Imaging. 2023 Dec 1;14(1).
30. Golestan A, Tahmasebi A, Maghsoodi N, Faraji SN, Irajie C, Ramezani A. Unveiling promising breast cancer biomarkers: an integrative approach combining bioinformatics analysis and experimental verification. BMC Cancer. 2024 Jan 31;24(1):155.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Luis Felipe Matute C., Sebastián Israel Sotomayor E., Marcelo Isaías López B.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Eres libre de:
- Compartir : copiar y redistribuir el material en cualquier medio o formato
- Adaptar : remezclar, transformar y desarrollar el material
- El licenciante no puede revocar estas libertades siempre y cuando usted cumpla con los términos de la licencia.
En los siguientes términos:
- Atribución : Debe otorgar el crédito correspondiente , proporcionar un enlace a la licencia e indicar si se realizaron cambios . Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o a su uso.
- No comercial : no puede utilizar el material con fines comerciales .
- CompartirIgual — Si remezcla, transforma o construye sobre el material, debe distribuir sus contribuciones bajo la misma licencia que el original.
- Sin restricciones adicionales : no puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otros hacer algo que la licencia permite.
